Benefits of continued cyclosporine through an indigent drug program

American Journal of Kidney Diseases

Volumn 28, Issue 4, 1996, Pages 572-577

  Sanders, Charles E ^a   Julian, Bruce A ^b   Gaston, Robert S ^b   Deierhoi, Mark H ^b   Diethelm, Arnold G ^b   Curtis, John J ^b  

^a University of Alabama at Birmingham   (United States)

^b NONE

Author keywords

blacks; compliance; cyclosporine; Kidney transplantation; socioeconomics

Indexed keywords

CYCLOSPORIN;

ADULT; ARTICLE; COHORT ANALYSIS; DRUG WITHDRAWAL; FEMALE; GRAFT REJECTION; HEALTH PROGRAM; HUMAN; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MEDICARE; PATIENT COMPLIANCE; POVERTY; RECIPIENT; RISK BENEFIT ANALYSIS; SOCIOECONOMICS;

EID: 0029795382     PISSN: 02726386     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0272-6386(96)90469-2     Document Type: Article

References (27)

1. Sanders CE, Curtis JJ, Julian BA, Gaston RS, Jones PA, Laskow DA, Deierhoi MH, Barber WH, Diethelm AG: Tapering or discontinuing cyclosporine for financial reasons - A single center experience. Am J Kidney Dis 21:9-15, 1993
2. Butkus DE, Meydrech EF, Raju SS: Racial differences in the survival of cadaveric renal allografts. N Engl J Med 327:840-845, 1992
3. Schweizer RT, Rovelli M, Palmeri D, Vossler E, Hull D, Bartus S: Noncompliance in organ transplant recipients. Transplantation 49:374-377, 1990
4. Dubovsky EV, Russell CD: Radionuclide evaluation of renal transplants. Semin Nucl Med 18:181-198, 1988
5. Opelz G: Superior long-term kidney graft survival in patients on maintenance immunosuppression with cyclosporine and azathioprine. Transplant Proc 25:1289-1290, 1993
6. Beveridge T, Calne RY: Cyclosporine in cadaveric renal transplantation. Transplantation 59:1568-1570, 1995
7. Kasiske BL, Heim-Duthoy K, Ma JZ: Elective cyclosporine withdrawal after renal transplantation. JAMA 269:395-400, 1993
8. Kasiske BL: Cyclosporine withdrawal after renal transplantation: Does it affect graft loss? J Nephrol 8:65-66, 1995
9. Heim-Duthoy KL, Chitwood KK, Tortorice KL, Massy ZA, Kasiske BL: Elective cyclosporine withdrawal 1 year after renal transplantation. Am J Kidney Dis 24:846-853, 1994
10. Pedersen EB, Hansen HE, Kornerup HJ, Madsen S, Sørensen AWS: Long-term graft survival after conversion from cyclosporin to azathioprine 1 year after renal transplantation. A prospective, randomized study from 1 to 6 years after transplantation. Nephrol Dial Transplant 8:250-254, 1993
11. Matas AJ, Gillingham KJ, Payne WD, Najarian JS: The impact of an acute rejection episode on long-term renal allograft survival (t 1/2). Transplantation 57:857-859, 1994
12. Basadonna GP, Matas AJ, Gillingham KJ, Payne WD, Dunn DL, Sutherland DE, Gores PF, Gruessner RW, Najarian JS: Early versus late acute renal allograft rejection: Impact on chronic rejection. Transplantation 55:993-995, 1993
13. Butkus DE, Meydrech EF, Raju SS: Racial differences in the survival of cadaveric renal allografts. N Engl J Med 327:840-845, 1992
14. Ojo AO, Port FK, Held PJ, Wolfe RA, Turenne MN, Chung E, Mauger EA, Leichtman AB: Inferior outcome of two-haplotype matched renal transplants in blacks: Role of early rejection. Kidney Int 48:1592-1599, 1995
15. Kondo K, Shibue T, Iwaki Y, Terasaki PI: Racial effect on kidney transplants, in Terasaki PI (ed): Clinical Transplants. Los Angeles, CA, UCLA Tissue Typing Laboratory, 1987, pp 339-349
16. Koyama H, Cecka JM, Terasaki PI: Kidney transplants in black recipients. Transplantation 57:1064-1068, 1994
17. Smith SR, Minda SA, Samsa GP, Harrell FE, Gunnells CJ, Coffman TM, Butterly DW: Late withdrawal of cyclosporine in stable renal transplant recipients. Am J Kidney Dis 26:487-494, 1995
18. Kiley DJ, Lam CS, Pollak R: A study of treatment compliance following kidney transplantation. Transplantation 55:51-56, 1993
19. Kalil RSN, Heim-Duthoy KL, Kasiske BL: Patients with a low income have reduced renal allograft survival. Am J Kidney Dis 20:63-69, 1992
20. Kerman RH, Kimball PM, Van Buren CT, Lewis RM, Kahan BD: Possible contribution of pretransplant immune responder status to renal allograft survival differences of black versus white recipients. Transplantation 51:338-342, 1991
21. Kerman RH, Kimball PM, Van Buren CT, Lewis RM, Kahan BD: Stronger immune responsiveness of blacks vs whites may account for renal allograft survival differences. Transplant Proc 23:380-382, 1991
22. Ward M, Lazda VA, Gaddis PJ, Stormoen BM, Smith Y, Fabrega AJ, Pollak R: In vitro response to immunosuppressive agents in blacks. Transplant Proc 25:2470-2471, 1993
23. Hricik DE, Whalen CC, Lautman J, Bartucci MR, Moir EJ, Mayes JT, Schulak JA: Withdrawal of steroids after renal transplantation - Clinical predictors of outcome. Transplantation 53:41-45, 1992
24. Neylan JF, Deierhoi MH: Dose-dependent prevention of acute renal transplant rejection in African-Americans receiving mycophenolate mofetil. American Society of Transplant Physicians, 14th Annual Meeting, Chicago, IL, 1995, p 119 (abstr)
25. Didlake RH, Dreyfus K, Kerman RH, Van Buren CT, Kahan BD: Patient noncompliance: A major cause of late graft failure in cyclosporine-treated renal transplants. Transplant Proc 20:63-69, 1988 (suppl 3)
26. Gaston RS, Hudson SL, Deierhoi MH, Barber WH, Laskow DA, Julian BA, Curtis JJ, Barger BO, Shroyer TW, Diethelm AG: Improved survival of primary cadaveric renal allografts in blacks with quadruple immunosuppression. Transplantation 53:103-109, 1992
27. Diethelm AG, Deierhoi MH, Hudson SL, Laskow DA, Julian BA, Gaston RS, Bynon JS, Curtis JJ: Progress in renal transplantation - A single center study of 3359 patients over 25 years. Ann Surg 221:446-458, 1995